MarketWatch

Boehringer Ingelheim launches VETMEDIN(R) Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

-- Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1 -- Previous studies have shown that VETMEDIN(R) could help improve the ...
WDET 101.9 FM

House committee opens hearings on bill to ban medical research on dogs

The bill would outlaw medical research and testing that could cause “pain or distress” in dogs. It’s aimed largely ...
WKRN-TV

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

DULUTH, Ga, Nov. 22, 2024 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, launched VETMEDIN ® Solution, the first oral solution approved by the U.S. Food and Drug ...
Longview News-Journal

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

DULUTH, Ga, Nov. 22, 2024 /CNW/ -- Boehringer Ingelheim, a global leader in animal health, launched VETMEDIN ® Solution, the first oral solution approved by the U.S. Food and Drug Administration (FDA) ...